Estimates Revisions Clinuvel Pharmaceuticals Limited Nasdaq
Stocks
CUVL
US1887691038
Pharmaceuticals
|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 5.780 USD | -0.17% |
|
-2.03% | -31.84% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Clinuvel Pharmaceuticals Limited(CUV)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Clinuvel Pharmaceuticals Limited(CUV)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Clinuvel Pharmaceuticals Limited(CUV)
EBIT
Dividend / Share (DPS)
Data source:
Clinuvel Pharmaceuticals Limited(CUV)
Cash or Net Debt
- Stock Market
- Stocks
- CUV Stock
- CUVL Stock
- Consensus Clinuvel Pharmaceuticals Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
